Cardiotoxic effects of venom phospholipase A2 are not due to phospholipid hydrolytic products

This publication has 29 references indexed in Scilit:

• Dissociation of pharmacological and enzymatic activities of snake venom phospholipases A2 by modification of carboxylate groups
  Biochemical Pharmacology, 1983
• Ethoxyformylation and guanidination of snake venom phospholipases A2: Effects on enzymatic activity, lethality and some pharmacological properties
  Toxicon, 1983
• Dissociation between enzymatic activity and pharmacological properties of snake venom phospholipases A2
  Toxicon, 1983
• Basic phospholipase A2 from Naja nigricollis snake venom: Phospholipid hydrolysis and effects of electrical and contractile activity of the rat heart
  Toxicology and Applied Pharmacology, 1982
• Relationship between catalysis and toxicological properties of three phospholipases A2 from elapid snake venoms
  Toxicology and Applied Pharmacology, 1981
• Effects of arginine modification of Naja nigricollis and Naja naja atra snake venom phospholipases A2 on enzymatic activity, lethality and anticoagulant action
  Toxicon, 1981
• Dissociation of enzymatic activity from lethality and pharmacological properties by carbamylation of lysines in Naja nigricollis and Naja naja atra snake venom phospholipases A2
  Toxicon, 1981
• Comparison of a relatively toxic phospholipase A2 from Naja nigricollis snake venom with that of a relatively non-toxic phospholipase A2 from Hemachatus haemachatus snake venom—II
  Biochemical Pharmacology, 1980
• Comparison of a relatively toxic phospholipase A2 from Naja nigricollis snake venom with that of a relatively non-toxic phospholipase A2 from Hemachatus haemachatus snake venom—I
  Biochemical Pharmacology, 1980
• Accumulation of lysophosphoglycerides with arrhythmogenic properties in ischemic myocardium.
  Journal of Clinical Investigation, 1978